TGFB1 and neoplasm: The TGF-β is also considered an inducer of receptor-regulated Smads (R-Smads) [19], thereby inhibiting the EMT by suppressing the activation of pathways related to TGF-β, which might comprehend a novel strategy to inhibit tumor progression.